CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

Deep Dive - Tissue Dissociation Solution

Preserving Biological Fidelity in Tissue Dissociation

By

Life Sciences Review | Friday, May 15, 2026

Tissue dissociation has become a much more important step in modern single-cell research than many laboratories once assumed. As scRNA-seq, flow cytometry and high-resolution cellular profiling become more central to translational and discovery research, scientists are paying closer attention to what happens to a sample before sequencing or analysis even begins. Increasingly, the concern is not just whether enough cells can be recovered, but whether the dissociation process itself changes the biology researchers are trying to measure.


Traditional enzymatic workflows still dominate much of the market, but they also come with growing concerns. Researchers have reported issues ranging from altered surface-marker expression to the loss of fragile or rare cell populations during processing. In areas such as immunology, neuroscience and tumor biology, those distortions can significantly affect downstream interpretation. A sequencing dataset may look technically strong while still misrepresenting the original tissue environment because sensitive cell types were damaged, stressed or selectively lost during preparation.


That has shifted attention toward tissue dissociation methods focused more on preservation than speed alone. Many labs now want workflows that maintain tissue heterogeneity and reduce cellular stress throughout processing, especially when working with delicate populations. Brain tissue is one of the clearest examples. Neurons and astrocytes can be particularly difficult to recover intact using conventional enzymatic methods, making biological preservation a much larger priority in neuroscience-focused workflows.


Researchers are also becoming more sensitive to variability introduced through repeated handling, heating steps and prolonged chemical digestion. Small differences in processing conditions can create reproducibility problems across experiments or research sites, particularly in large-scale single-cell studies. As a result, procurement teams are increasingly evaluating systems that simplify handling steps and create more controlled preparation environments. Preserving fragile surface markers has become another important factor, especially for sorting applications where the markers themselves define the populations researchers are attempting to isolate.


Cost considerations are pushing the same trend. Single-cell sequencing and advanced cytometry workflows are expensive, and poor dissociation quality can compromise an entire experiment before analysis begins. Many organizations are therefore looking beyond simple cell yield and focusing more heavily on whether recovered cells remain biologically representative and usable for downstream applications.


Cellsonics has positioned its platform around that preservation-focused approach to tissue dissociation. Its SimpleFlow system combines mechanical mincing with proprietary acoustic technology designed to generate high-quality cells while minimizing disruption to the original tissue environment. The company’s approach reflects growing concern within the research community that aggressive enzymatic workflows can alter cell populations before characterization even begins.


The platform appears particularly relevant for researchers working with fragile or difficult-to-recover populations. Comparative work highlighted by Cellsonics has shown stronger recovery of neurons and astrocytes relative to some conventional enzymatic methods, while early-access users have also reported improved preservation of sensitive surface markers during sorting workflows. The cartridge-based design integrates tissue mincing directly into the system and operates within a cooled water bath intended to reduce heat exposure and cellular stress. For organizations prioritizing biological fidelity in single-cell sequencing and cytometric analysis, Cellsonics offers a workflow designed around preserving the native characteristics of the tissue rather than maximizing dissociation intensity alone.


Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/deep-dive/preserving-biological-fidelity-in-tissue-dissociation-nwid-3346.html